CSPC Pharmaceutical Group (1093N) Financial Statements

0 Followers

CSPC Pharmaceutical Group Financial Overview

CSPC Pharmaceutical Group's market cap is currently $238.14B. The company's EPS TTM is $0.65; its P/E ratio is 12.57; CSPC Pharmaceutical Group is scheduled to report earnings on August 20, 2026, and the estimated EPS forecast is $0.31. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 25.33B	¥ 29.54B	¥ 31.47B	¥ 31.59B	¥ 27.41B
Gross Profit	¥ 16.62B	¥ 20.67B	¥ 22.19B	¥ 22.73B	¥ 20.79B
Operating Income	¥ 3.87B	¥ 5.45B	¥ 7.01B	¥ 6.93B	¥ 6.14B
EBITDA	¥ 5.24B	¥ 7.18B	¥ 8.59B	¥ 8.85B	¥ 7.57B
Net Income	¥ 3.78B	¥ 4.41B	¥ 5.88B	¥ 6.22B	¥ 5.51B
Balance Sheet
Cash & Short-Term Investments	¥ 8.87B	¥ 7.75B	¥ 13.09B	¥ 13.87B	¥ 10.73B
Total Assets	¥ 46.72B	¥ 44.36B	¥ 46.28B	¥ 41.18B	¥ 34.68B
Total Debt	¥ 641.38M	¥ 507.33M	¥ 706.90M	¥ 582.54M	¥ 93.87M
Net Debt	¥ -5.45B	¥ -5.86B	¥ -11.31B	¥ -9.72B	¥ -9.17B
Total Liabilities	¥ 12.15B	¥ 10.52B	¥ 11.26B	¥ 10.06B	¥ 7.91B
Stockholders' Equity	¥ 33.19B	¥ 32.24B	¥ 33.20B	¥ 29.77B	¥ 25.94B
Cash Flow
Free Cash Flow	¥ 3.99B	¥ 1.74B	¥ 2.29B	¥ 6.62B	¥ 2.88B
Operating Cash Flow	¥ 5.90B	¥ 4.26B	¥ 4.18B	¥ 8.10B	¥ 4.64B
Investing Cash Flow	¥ -4.13B	¥ -4.41B	¥ 607.27M	¥ -7.19B	¥ -637.33M
Financing Cash Flow	¥ -2.44B	¥ -5.11B	¥ -2.30B	¥ -1.95B	¥ -2.20B

CSPC Pharmaceutical Group Earnings and Revenue History

Income Statement >

CSPC Pharmaceutical Group Debt to Assets

Balance Sheet >

CSPC Pharmaceutical Group Cash Flow

Cash Flow >

CSPC Pharmaceutical Group Forecast EPS vs Actual EPS

Earnings >